Tag Archives: More

With Gamifant launch rolling, Sobi unveils more data backing the rare disease med

SAN DIEGO—Armed with last month’s FDA approval, Sobi is rolling out its newly minted rare disease drug Gamifant with a small, targeted sales force, and Monday it unveiled more of the data that won the agency’s favor in the first place. In a phase 2/3 trial of Gamifant in primary haemophagocytic lymphohistiocytosis (HLH), 64.7% of… Read More »

Asthma More Prevalent in Obese and Overweight Kids

An estimated 6.1 million children suffer from asthma, making the respiratory illness the most common chronic condition among kids, according to the American Lung Association. Now, new findings published in the journal Pediatrics suggest that overweight and obese youngsters face a higher risk of developing asthma compared with their healthy-sized counterparts, reports DukeHealth. For the… Read More »